AAAAAA

   
Results: 1-20 |
Results: 20
AUGMENTATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE (ARA-C) CYTOTOXICITY IN LEUKEMIA-CELLS BY COADMINISTRATION WITH ANTISIGNALLING DRUGS
Authors: FREUND A BOOS J HARKIN S SCHULTZEMOSGAU M VEERMAN G PETERS GJ GESCHER A
Citation: A. Freund et al., AUGMENTATION OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE (ARA-C) CYTOTOXICITY IN LEUKEMIA-CELLS BY COADMINISTRATION WITH ANTISIGNALLING DRUGS, European journal of cancer, 34(6), 1998, pp. 895-901
POSTCONFLUENT MULTILAYERED CELL-LINE CULTURES FOR SELECTIVE SCREENINGOF GEMCITABINE
Authors: SMITSKAMPWILMS E PINEDO HM VEERMAN G VANHAPEREN VWTR PETERS GJ
Citation: E. Smitskampwilms et al., POSTCONFLUENT MULTILAYERED CELL-LINE CULTURES FOR SELECTIVE SCREENINGOF GEMCITABINE, European journal of cancer, 34(6), 1998, pp. 921-926
PHASE-I TRIAL AND PHARMACOKINETICS OF BETA-D-GLUCOSYLISOPHOSPHORAMIDEMUSTARD (D-19575) ADMINISTERED AS A 6-HOUR INFUSION EVERY 3 WEEKS - AN EORTC-ECSG STUDY
Authors: BRIASOULIS E JUDSON I PAVLIDIS N BEALE P GROOT Y VEERMAN G SCHUESSLER M RAMMOU D WALKER R HANAUSKE A
Citation: E. Briasoulis et al., PHASE-I TRIAL AND PHARMACOKINETICS OF BETA-D-GLUCOSYLISOPHOSPHORAMIDEMUSTARD (D-19575) ADMINISTERED AS A 6-HOUR INFUSION EVERY 3 WEEKS - AN EORTC-ECSG STUDY, Annals of oncology, 9, 1998, pp. 616-616
MECHANISM(S) OF THE SCHEDULE-DEPENDENT INTERACTION BETWEEN GEMCITABINE (DFDC) AND CISPLATIN (CDDP) IN THE MURINE NONSMALL CELL LUNG (NSCL) TUMOR LEWIS LUNG
Authors: VANMOORSEL CJA VOORN DA VEERMAN G COMIJN EM SMID K VANDERVIJGH WJF POSTMUS PE VERMORKEN JB PINEDO HM PETERS GJ
Citation: Cja. Vanmoorsel et al., MECHANISM(S) OF THE SCHEDULE-DEPENDENT INTERACTION BETWEEN GEMCITABINE (DFDC) AND CISPLATIN (CDDP) IN THE MURINE NONSMALL CELL LUNG (NSCL) TUMOR LEWIS LUNG, Annals of oncology, 9, 1998, pp. 187-187
A PHASE-I TRIAL OF D19575, A BETA-D-GLUCOSE-LINKED ISOPHOSPHORAMIDE MUSTARD GIVEN AS A 6-HOUR INFUSION
Authors: BRIASOULIS E JUDSON I PAVLIDIS N BEALE P WANDERS J GROOT Y VEERMAN G LOCHER M SCHUESSLER M TZAMAKOU E RAMMOU D WOLF L WALKER R HANAUSKE A
Citation: E. Briasoulis et al., A PHASE-I TRIAL OF D19575, A BETA-D-GLUCOSE-LINKED ISOPHOSPHORAMIDE MUSTARD GIVEN AS A 6-HOUR INFUSION, Annals of oncology, 9, 1998, pp. 473-473
COLLATERAL SENSITIVITY OF GEMCITABINE OF HUMAN MULTIDRUG-RESISTANT CANCER-CELLS
Authors: PETERS GJ BERGMAN AM JENSEN PB SEHESTED M MUNCHPETERSEN B VEERMAN G VOORN DA PINEDO HM
Citation: Gj. Peters et al., COLLATERAL SENSITIVITY OF GEMCITABINE OF HUMAN MULTIDRUG-RESISTANT CANCER-CELLS, Annals of oncology, 9, 1998, pp. 565-565
COMBINATION CHEMOTHERAPY STUDIES WITH GEMCITABINE
Authors: VANMOORSEL CJA VEERMAN G BERGMAN AM GUECHEV A VERMORKEN JB POSTMUS PE PETERS GJ
Citation: Cja. Vanmoorsel et al., COMBINATION CHEMOTHERAPY STUDIES WITH GEMCITABINE, Seminars in oncology, 24(2), 1997, pp. 17-23
SYNERGISTIC INTERACTION BETWEEN CISPLATIN AND GEMCITABINE IN-VITRO
Authors: BERGMAN AM VANHAPEREN VWTR VEERMAN G KUIPER CM PETERS GJ
Citation: Am. Bergman et al., SYNERGISTIC INTERACTION BETWEEN CISPLATIN AND GEMCITABINE IN-VITRO, Clinical cancer research, 2(3), 1996, pp. 521-530
IN-VITRO ANTIPROLIFERATIVE EFFECTS, TOXICITY PROFILES IN-VIVO IN MICEAND ANTITUMOR-ACTIVITY IN TUMOR-BEARING MICE OF 4 DIORGANOTIN COMPOUNDS
Authors: GIELEN M WILLEM R BOUHDID A DEVOS D KUIPER CM VEERMAN G PETERS GJ
Citation: M. Gielen et al., IN-VITRO ANTIPROLIFERATIVE EFFECTS, TOXICITY PROFILES IN-VIVO IN MICEAND ANTITUMOR-ACTIVITY IN TUMOR-BEARING MICE OF 4 DIORGANOTIN COMPOUNDS, Oncology Reports, 3(3), 1996, pp. 583-587
ANTITUMOR-ACTIVITY OF PROLONGED AS COMPARED WITH BOLUS ADMINISTRATIONOF 2',2'-DIFLUORODEOXYCYTIDINE IN-VIVO AGAINST MURINE COLON TUMORS
Authors: VEERMAN G VANHAPEREN VWTR VERMORKEN JB NOORDHUIS P BRAAKHUIS BJM PINEDO HM PETERS GJ
Citation: G. Veerman et al., ANTITUMOR-ACTIVITY OF PROLONGED AS COMPARED WITH BOLUS ADMINISTRATIONOF 2',2'-DIFLUORODEOXYCYTIDINE IN-VIVO AGAINST MURINE COLON TUMORS, Cancer chemotherapy and pharmacology, 38(4), 1996, pp. 335-342
PRECLINICAL COMBINATION THERAPY WITH GEMCITABINE AND MECHANISMS OF RESISTANCE
Authors: PETERS GJ VANHAPEREN VWTR BERGMAN AM VEERMAN G SMITSKAMPWILMS E VANMOORSEL CJA KUIPER CM BRAAKHUIS BJM
Citation: Gj. Peters et al., PRECLINICAL COMBINATION THERAPY WITH GEMCITABINE AND MECHANISMS OF RESISTANCE, Seminars in oncology, 23(5), 1996, pp. 16-24
REGULATION OF PHOSPHORYLATION OF DEOXYCYTIDINE AND 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) - EFFECTS OF CYTIDINE 5'-TRIPHOSPHATE AND URIDINE 5'-TRIPHOSPHATE IN RELATION TO CHEMOSENSITIVITY FOR 2',2'-DIFLUORODEOXYCYTIDINE
Authors: VANHAPEREN VWTR VEERMAN G VERMORKEN JB PINEDO HM PETERS GJ
Citation: Vwtr. Vanhaperen et al., REGULATION OF PHOSPHORYLATION OF DEOXYCYTIDINE AND 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) - EFFECTS OF CYTIDINE 5'-TRIPHOSPHATE AND URIDINE 5'-TRIPHOSPHATE IN RELATION TO CHEMOSENSITIVITY FOR 2',2'-DIFLUORODEOXYCYTIDINE, Biochemical pharmacology, 51(7), 1996, pp. 911-918
3-DIMENSIONAL CELL-CULTURES AS A MODEL SYSTEM TO EVALUATE THE BIOLOGICAL-ACTIVITY OF GEMCITABINE (2',2'-DIFLUORO-2'DEOXYCYTIDINE)
Authors: PETERS GJ SMITSKAMPWILMS E VEERMAN G PIZAO PE VANHAPEREN VWTR PINEDO HM
Citation: Gj. Peters et al., 3-DIMENSIONAL CELL-CULTURES AS A MODEL SYSTEM TO EVALUATE THE BIOLOGICAL-ACTIVITY OF GEMCITABINE (2',2'-DIFLUORO-2'DEOXYCYTIDINE), Nucleosides & nucleotides, 14(3-5), 1995, pp. 661-664
INDUCTION OF RESISTANCE TO 2',2'-DIFLUORODEOXYCYTIDINE IN THE HUMAN OVARIAN-CANCER CELL-LINE A2780
Authors: VANHAPEREN VWTR VEERMAN G ERIKSSON S STEGMANN APA PETERS GJ
Citation: Vwtr. Vanhaperen et al., INDUCTION OF RESISTANCE TO 2',2'-DIFLUORODEOXYCYTIDINE IN THE HUMAN OVARIAN-CANCER CELL-LINE A2780, Seminars in oncology, 22(4), 1995, pp. 35-41
SCHEDULE-DEPENDENT ANTITUMOR EFFECT OF GEMCITABINE IN IN-VIVO MODEL SYSTEMS
Authors: BRAAKHUIS BJM VANHAPEREN VWTR BOVEN E VEERMAN G PETERS GJ
Citation: Bjm. Braakhuis et al., SCHEDULE-DEPENDENT ANTITUMOR EFFECT OF GEMCITABINE IN IN-VIVO MODEL SYSTEMS, Seminars in oncology, 22(4), 1995, pp. 42-46
INTERACTION BETWEEN CISPLATIN AND GEMCITABINE IN-VITRO AND IN-VIVO
Authors: PETERS GJ BERGMAN AM VANHAPEREN VWTR VEERMAN G KUIPER CM BRAAKHUIS BJM
Citation: Gj. Peters et al., INTERACTION BETWEEN CISPLATIN AND GEMCITABINE IN-VITRO AND IN-VIVO, Seminars in oncology, 22(4), 1995, pp. 72-79
DEVELOPMENT AND MOLECULAR CHARACTERIZATION OF A 2',2'-DIFLUORODEOXYCYTIDINERESISTANT VARIANT OF THE HUMAN OVARIAN-CARCINOMA CELL-LINE A2780
Authors: VANHAPEREN VWTR VEERMAN G ERIKSSON S BOVEN E STEGMANN APA HERMSEN M VERMORKEN JB PINEDO HM PETERS GJ
Citation: Vwtr. Vanhaperen et al., DEVELOPMENT AND MOLECULAR CHARACTERIZATION OF A 2',2'-DIFLUORODEOXYCYTIDINERESISTANT VARIANT OF THE HUMAN OVARIAN-CARCINOMA CELL-LINE A2780, Cancer research, 54(15), 1994, pp. 4138-4143
SCHEDULE DEPENDENCE OF SENSITIVITY TO 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) IN RELATION TO ACCUMULATION AND RETENTION OF ITS TRIPHOSPHATE IN SOLID TUMOR-CELL LINES AND SOLID TUMORS
Authors: VANHAPEREN VWTR VEERMAN G BOVEN E NOORDHUIS P VERMORKEN JB PETERS GJ
Citation: Vwtr. Vanhaperen et al., SCHEDULE DEPENDENCE OF SENSITIVITY TO 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) IN RELATION TO ACCUMULATION AND RETENTION OF ITS TRIPHOSPHATE IN SOLID TUMOR-CELL LINES AND SOLID TUMORS, Biochemical pharmacology, 48(7), 1994, pp. 1327-1339
DEOXYCYTIDINE KINASE AND DEOXYCYTIDINE DEAMINASE ACTIVITIES IN HUMAN TUMOR XENOGRAFTS
Authors: VANHAPEREN VWTR VEERMAN G BRAAKHUIS BJM VERMORKEN JB BOVEN E LEYVA A PETERS GJ
Citation: Vwtr. Vanhaperen et al., DEOXYCYTIDINE KINASE AND DEOXYCYTIDINE DEAMINASE ACTIVITIES IN HUMAN TUMOR XENOGRAFTS, European journal of cancer, 29A(15), 1993, pp. 2132-2137
2',2'-DIFLUORO-DEOXYCYTIDINE (GEMCITABINE) INCORPORATION INTO RNA ANDDNA OF TUMOR-CELL LINES
Authors: VANHAPEREN VWTR VEERMAN G VERMORKEN JB PETERS GJ
Citation: Vwtr. Vanhaperen et al., 2',2'-DIFLUORO-DEOXYCYTIDINE (GEMCITABINE) INCORPORATION INTO RNA ANDDNA OF TUMOR-CELL LINES, Biochemical pharmacology, 46(4), 1993, pp. 762-766
Risultati: 1-20 |